En español
NIDA

Testing and Linkage to HIV Care in China: a Cluster Randomized Trial

The high proportions of patients lost at each step along the continuum of HIV care result in suboptimal benefits of life-saving antiretroviral therapy (ART) in developing countries.  The goal of this study is to determine whether implementation of two structural interventions based on the Seek, Test, Treat and Retain strategy will increase the proportion of HIV-positive, treatment-eligible patients, who are identified and linked to ART and who achieve VL suppression, thereby reducing mortality.  The proposed study will examine the effects of two hospital-based structural interventions, one designed to ensure that HIV-positive individuals receive a confirmed HIV diagnosis and determination of treatment eligibility, and the other designed to ensure that treatment-eligible patients achieve VL suppression after initiating ART.

CTN Protocol ID: 
CTN-0056
Enrollment Status: 
Enrolling
Principal Investigator(s)
Walter Ling, M.D.
Director
Integrated Substance Abuse Programs
University of California, Los Angeles
11075 Santa Monica Boulevard
Suite 200
Los Angeles, CA 90025
lwalter@ucla.edu

Zunyou Wu, M.D., Ph.D.
Director
National Center for AIDS/STD Control & Prevention
Chinese Center for Diseases Control and Prevention
155 Changbai Road
Changping District
Beijing, China102206
wuzunyou@chinaaids.cn

Participating Nodes and Community Treatment Programs

Pacific Region Node (Lead Node)

  • Bobai County People's Hospital
  • Daxin County People's Hospital
  • Duan County People's Hospital
  • Fusui County People's Hospital
  • Lingshan County People's Hospital
  • Lingui County People's Hospital
  • Lipu County People's Hospital
  • Longan County People's Hospital
  • Ningming County People's Hospital
  • Rongan County People's Hospital
  • Xiangzhou County People's Hospital

Get this Publication

    Blending Initiative

    blending logo

    Formed with SAMHSA to reduce the gap between research results and treatment.